Drawing for AMTHRYO

USPTO serial 79397925

AMTHRYO

Reviewed by CopyMark Law Group

Reg. 7665846Status 700Registered
Filing date
Status date
Registration date
Jan 28, 2025
Examiner
KHOURI, SANI PHILIPPE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AMTHRYO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cara M. Kearney

Cara M. Kearney AstraZeneca Pharmaceuticals LP1800 Concord PikeA2CWilmington, DE 19850-5437

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of hypoparathyroidism, including eneboparatide.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 20, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 20, 2026CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Aug 1, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 1, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 1, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 18, 2025CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 12, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 27, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 28, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 28, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 9, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 9, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 4, 2024NPUBNOTICE OF PUBLICATION—
Nov 14, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 12, 2024DOCKASSIGNED TO EXAMINER—
Jul 7, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 1, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 1, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 20, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance